LynnLeeMD

Research Assistant Professor, Division of Oncology, Cincinnati Children's Hospital Medical Center

Dr. Lee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2016
Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2010 - 2013
Emory University School of MedicineClass of 2010

PubMed

27 citations
An in vivo CRISPR screening platform for prioritizing therapeutic targets in AML.
Shan Lin, Clément Larrue, Nastassja K. Scheidegger, Bo Kyung A. Seong, Neekesh V. Dharia
Cancer Discovery. 2021-01-01
9 citations
LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for Mixed Lineage Leukemia-Rearranged acute leukemia.
Gabriel Gracia-Maldonado, Jason Clark, Matthew Burwinkel, Brenay Greenslade, Mark Wunderlich
Haematologica. 2021-04-29
3 citations
Treatment of posttransplant lymphoproliferative disorder with poor prognostic features in children and young adults: Short-course EPOCH regimens are safe and effective
Jeremy D. Rubinstein, Rachana Shah, Erin H. Breese, Karen Burns, Jennifer Mangino
Pediatric Blood & Cancer. 2021-05-21

Abstracts/Posters

V2 Trial: A Phase I Study of Venetoclax Combined with CPX-351 for Children, Adolescents and Young Adults with Relapsed or Refractory Acute Leukemia
Lynn Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Innate Immune Signaling Suppresses Acute Leukemia By Modifying MYC Oncogenic Activity
Lynn Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019